ChromaDex (NASDAQ:CDXC) Coverage Initiated by Analysts at StockNews.com

Stock analysts at StockNews.com began coverage on shares of ChromaDex (NASDAQ:CDXC) in a research note issued to investors on Monday. The brokerage set a “buy” rating on the stock.

Several other research firms have also recently commented on CDXC. LADENBURG THALM/SH SH raised their price target on ChromaDex from $6.80 to $8.10 and gave the company a “buy” rating in a report on Wednesday, March 5th. HC Wainwright reaffirmed a “buy” rating and issued a $11.00 target price on shares of ChromaDex in a research note on Monday, March 17th.

ChromaDex Stock Performance

The firm has a market capitalization of $611.50 million, a P/E ratio of 787.29 and a beta of 2.21. The business’s fifty day moving average is $6.16 and its two-hundred day moving average is $5.44. ChromaDex has a fifty-two week low of $2.31 and a fifty-two week high of $9.18.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Squarepoint Ops LLC acquired a new stake in shares of ChromaDex during the fourth quarter worth $555,000. Two Sigma Investments LP acquired a new stake in ChromaDex in the 4th quarter valued at approximately $675,000. State of Wyoming bought a new stake in shares of ChromaDex during the fourth quarter valued at about $39,000. Sherbrooke Park Advisers LLC bought a new position in ChromaDex in the 4th quarter valued at about $94,000. Finally, ProShare Advisors LLC bought a new stake in shares of ChromaDex in the 4th quarter worth $74,000. 15.41% of the stock is owned by institutional investors and hedge funds.

About ChromaDex

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products.